
### [NCIT:C8320](http://purl.obolibrary.org/obo/NCIT_C8320)
**Label:** Stage III Lymphoma

**Subclasses:** [NCIT:C8856](http://purl.obolibrary.org/obo/NCIT_C8856) (Stage III Diffuse Large B-Cell Lymphoma), [NCIT:C8878](http://purl.obolibrary.org/obo/NCIT_C8878) (Stage III Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8678](http://purl.obolibrary.org/obo/NCIT_C8678) (Stage III Angioimmunoblastic T-cell Lymphoma), [NCIT:C8139](http://purl.obolibrary.org/obo/NCIT_C8139) (Stage III Adult Burkitt Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8655](http://purl.obolibrary.org/obo/NCIT_C8655) (Stage III Lymphoplasmacytic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8138](http://purl.obolibrary.org/obo/NCIT_C8138) (Stage III Adult Lymphoblastic Lymphoma), [NCIT:C8850](http://purl.obolibrary.org/obo/NCIT_C8850) (Stage III Burkitt Lymphoma), [NCIT:C94793](http://purl.obolibrary.org/obo/NCIT_C94793) (Stage III Childhood Non-Hodgkin Lymphoma), [NCIT:C8872](http://purl.obolibrary.org/obo/NCIT_C8872) (Stage III B Lymphoblastic Lymphoma), [NCIT:C8674](http://purl.obolibrary.org/obo/NCIT_C8674) (Stage III Nasal Type NK/T-Cell Lymphoma), [NCIT:C3584](http://purl.obolibrary.org/obo/NCIT_C3584) (Stage III Hodgkin Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C3583](http://purl.obolibrary.org/obo/NCIT_C3583) (Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C7262](http://purl.obolibrary.org/obo/NCIT_C7262) (Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C8057](http://purl.obolibrary.org/obo/NCIT_C8057) (Stage III Childhood Hodgkin Lymphoma), [NCIT:C9187](http://purl.obolibrary.org/obo/NCIT_C9187) (Stage III Childhood Burkitt Lymphoma), [NCIT:C8692](http://purl.obolibrary.org/obo/NCIT_C8692) (Stage III Mature T- and NK-Cell Lymphoma), [NCIT:C3582](http://purl.obolibrary.org/obo/NCIT_C3582) (Stage III Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C5087](http://purl.obolibrary.org/obo/NCIT_C5087) (Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8132](http://purl.obolibrary.org/obo/NCIT_C8132) (Stage III Grade 3 Follicular Lymphoma), [NCIT:C8482](http://purl.obolibrary.org/obo/NCIT_C8482) (Stage III Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8667](http://purl.obolibrary.org/obo/NCIT_C8667) (Stage III T-Cell Non-Hodgkin Lymphoma), [NCIT:C8128](http://purl.obolibrary.org/obo/NCIT_C8128) (Stage III Small Lymphocytic Lymphoma), [NCIT:C8844](http://purl.obolibrary.org/obo/NCIT_C8844) (Stage III B-Cell Non-Hodgkin Lymphoma), [NCIT:C8129](http://purl.obolibrary.org/obo/NCIT_C8129) (Stage III Grade 1 Follicular Lymphoma), [NCIT:C8866](http://purl.obolibrary.org/obo/NCIT_C8866) (Stage III Nodal Marginal Zone Lymphoma), [NCIT:C8522](http://purl.obolibrary.org/obo/NCIT_C8522) (Stage III Non-Hodgkin Lymphoma), [NCIT:C8104](http://purl.obolibrary.org/obo/NCIT_C8104) (Stage III Adult Non-Hodgkin Lymphoma), [NCIT:C8861](http://purl.obolibrary.org/obo/NCIT_C8861) (Stage III Follicular Lymphoma), [NCIT:C8661](http://purl.obolibrary.org/obo/NCIT_C8661) (Stage III Anaplastic Large Cell Lymphoma), [NCIT:C8684](http://purl.obolibrary.org/obo/NCIT_C8684) (Stage III Enteropathy-Associated T-Cell Lymphoma), [NCIT:C9058](http://purl.obolibrary.org/obo/NCIT_C9058) (Stage III Childhood Lymphoblastic Lymphoma), [NCIT:C8483](http://purl.obolibrary.org/obo/NCIT_C8483) (Stage III Mantle Cell Lymphoma), [NCIT:C8484](http://purl.obolibrary.org/obo/NCIT_C8484) (Stage III Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C9034](http://purl.obolibrary.org/obo/NCIT_C9034) (Stage III Adult Hodgkin Lymphoma), [NCIT:C88157](http://purl.obolibrary.org/obo/NCIT_C88157) (Stage III Mycosis Fungoides and Sezary Syndrome), [NCIT:C8130](http://purl.obolibrary.org/obo/NCIT_C8130) (Stage III Grade 2 Follicular Lymphoma), [NCIT:C68682](http://purl.obolibrary.org/obo/NCIT_C68682) (Stage III Marginal Zone Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 55.00%
- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39963](http://purl.obolibrary.org/obo/NCIT_C39963) (Penile Bowenoid Papulosis))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 40.36%


